A recent study [76] has evaluated miRNA expression profiles in T1D without other pathologies, and it was observed that the development of a well-established disease, where patients are continuously treated with insulin, may differ from the onset of the disease and, more importantly, from other types of diabetes. This evidence concerns the gene INS and diabetes mellitus.